Form 4 for EW Edwards Lifesciences
Accepted 2024-02-16 00:00:00 ET · period of report 2024-02-16 · accession 0001225208-24-002345 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-02-16 | 2024-02-16 | EW | Ullem Scott B. | CFO, CVP | F - Tax | $86.04 | -174 | 19.1K | -0.9% | -$15.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-16 | F | D | 174 | $86.04 | 19,074 | D | — | — |